Introduction to the recommendations from the European Association for the Study of the Liver clinical practice guidelines on the management of cystic liver disease.
10.3760/cma.j.cn501113-20220719-00388
- Author:
Chen LIANG
1
;
Su Jun ZHENG
2
;
Zhong Ping DUAN
1
Author Information
1. The Department of Liver Center, Beijing YouAn Hospital, Capital Medical University, Beijing 100069, China Beijing Municipal Key Laboratory of Liver Failure and Artificial Liver Treatment Ｒesearch, Beijing YouAn Hospital, Capital Medical University, Beijing 100069, China.
2. The Department of Liver Center, Beijing YouAn Hospital, Capital Medical University, Beijing 100069, China.
- Publication Type:Journal Article
- MeSH:
Humans;
Liver Diseases/pathology*;
Cysts/pathology*;
Caroli Disease/diagnosis*;
Liver Neoplasms/therapy*;
Hamartoma
- From:
Chinese Journal of Hepatology
2022;30(9):931-933
- CountryChina
- Language:Chinese
-
Abstract:
The diagnosis of cystic liver disease has made great progress with the advent of enhanced imaging techniques. At the same time, its management has gradually improved over the past few decades, providing the basis for the development of appropriate diagnostic and treatment guidelines. To this end, the European Association for the Study of the Liver has developed clinical guidelines for the diagnosis and treatment of non-infectious cystic liver disease. This guideline put forward recommendations based on an in-depth review of the relevant literature for addressing clinical issues, including the diagnosis and treament of hepatic cysts, hepatic mucocystic tumors, biliary hamartomas, polycystic liver disease, Caroli disease or Caroli syndrome, biliary hamartomas, and peribiliary cyst.
